These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6430038)

  • 1. Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden.
    Wiholm BE; Westerholm B
    Acta Med Scand Suppl; 1984; 683():107-17. PubMed ID: 6430038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory decisions. Emphasis on safety issues.
    Strandberg K; Wiholm BE
    Med Toxicol; 1986; 1 Suppl 1():137-49. PubMed ID: 2950292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver damage from low-dose oral contraceptives.
    Lindgren A; Olsson R
    J Intern Med; 1993 Sep; 234(3):287-92. PubMed ID: 8354979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of adverse drug reactions to phenformin and metformin.
    Bergman U; Boman G; Wiholm BE
    Br Med J; 1978 Aug; 2(6135):464-6. PubMed ID: 678924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenic hazards of oral contraceptives analyzed in a national malformation register.
    Savolainen E; Saksela E; Saxén L
    Am J Obstet Gynecol; 1981 Jul; 140(5):521-4. PubMed ID: 7246686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic diseases in young women and the influence of oral contraceptives.
    Lidegaard O
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale for a post-marketing surveillance.
    Westerholm B
    Hum Reprod; 1987 Jan; 2(1):41-4. PubMed ID: 3571446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in cerebral thromboembolism among young women after introduction of low-dose oral contraceptives: an incidence study for the period 1980-1993.
    Lidegaard O
    Contraception; 1995 Aug; 52(2):85-92. PubMed ID: 8536452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive use: interview data versus pharmacy records.
    Norell SE; Boethius G; Persson I
    Int J Epidemiol; 1998 Dec; 27(6):1033-7. PubMed ID: 10024199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
    Grimes DA
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia associated with metoclopramide.
    Wiholm BE; Mortimer O; Boethius G; Häggström JE
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):545-7. PubMed ID: 6421373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
    BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular deaths before and after the appearance of oral contraceptives.
    Lidegaard O
    Acta Neurol Scand; 1987 Jun; 75(6):427-33. PubMed ID: 3630638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD; Lawrenson RA
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
    Le MG; Bachelot A; Doyen F; Kramar A
    Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and vascular disease.
    Sartwell PE; Stolley PD
    Epidemiol Rev; 1982; 4():95-109. PubMed ID: 6754411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.